ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2019 American Transplant Congress

    Belatacept Use in High Kidney Donor Profile Index Kidney Transplant Recipients

    D. Britt1, A. Gharabagi1, K. Botkin1, T. Horwedel2, C. Carthon1, J. Hagopian1

    1Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, 2Veloxis Pharmaceuticals, Cary, NC

    *Purpose: To determine whether the use of belatacept is associated with renal function preservation in kidney transplant recipients from donors with a kidney donor profile…
  • 2019 American Transplant Congress

    Early Rejection Outcomes with IL-2 vs. ATG Induction among Kidney Transplant Recipients Induction Differences with Early Steroid Withdrawal

    C. Burelli, A. Szczepanik, K. Yadav, E. Sanchez, M. Debroy, V. Humphreville, J. Rabets, A. Padiyar, N. Sarabu, A. Jittirat, A. Palanisamy, K. Chavin

    University Hospitals Cleveland Medical Center, Cleveland, OH

    *Purpose: Early steroid withdrawal in kidney transplant (Ktx) patients is controversial and has demonstrated an increased risk of acute rejection with similar long-term outcomes. Data…
  • 2019 American Transplant Congress

    Long-Term Exposure to Particulate Matter Air Pollution and the Risk of Graft Failure and Mortality in Kidney Transplant Recipients

    Y. Kim1, S. Kwon1, J. Park2, J. Lee3

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, 2Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, 3Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of

    *Purpose: Elevated levels of fine particulate matter, 10 μm in aerodynamic diameter (PM10) are associated with increased risk of cardiovascular outcomes and death, but their…
  • 2019 American Transplant Congress

    Pre-Transplant Multidimensional Flow Cytometric Analysis of Kidney Transplant Recipients Reveals Novel Immune Signature of Allograft Rejection

    P. Schroder1, J. S. Yi1, K. J. Weinhold1, C. Chan2, M. Joshi3, C. Walters3, J. Kwun1, S. J. Knechtle1

    1Department of Surgery, Duke University Medical Center, Durham, NC, 2Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, 3Substrate Services Core and Research Support, Duke University Medical Center, Durham, NC

    *Purpose: Multicolor flow cytometry and multiplex assay platforms have revolutionized immune cell phenotyping and functional analyses, but these powerful tools have not demonstrated clinically meaningful…
  • 2019 American Transplant Congress

    The Association of Kidney Transplant Center Volume with 3-Year Outcomes

    E. M. Sonnenberg1, J. B. Cohen2, J. Y. Hsu3, V. S. Potluri2, M. H. Levine1, P. L. Abt1, P. P. Reese2

    1Surgery, University of Pennsylvania, Philadelphia, PA, 2Renal Division, University of Pennsylvania, Philadelphia, PA, 3Biostatistics, University of Pennsylvania, Philadelphia, PA

    *Purpose: To assess if a center volume-outcome relationship exists for contemporary kidney transplantation, specifically in increased-risk scenarios including: diabetic recipients, elderly recipients (age>65) or recipients…
  • 2019 American Transplant Congress

    Outcomes in Preformed Donor-Specific Human Leukocyte Antibody Positive Living Kidney Transplant Recipients Desensitized with Intravenous Immunoglobulin and Rituximab

    Y. kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan, 2Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan

    *Purpose: Donor-specific antibody (DSA) is associated with antibody-mediated rejection (ABMR) and is a significant immunologic barrier to graft and patient survival. Pre-transplant desensitization therapy has…
  • 2019 American Transplant Congress

    Outcomes of Induction Therapy with Bortezomib and High-Dose Intravenous Immunoglobulin for Kidney Transplantation with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

    Department of Urology, Ehime University, Toon, Japan

    *Purpose: Preformed donor-specific anti-human leukocyte antigen (HLA) antibodies (DSAs) are known to increase the risk of antibody-mediated rejection (ABMR) and graft failure. However, effective methods…
  • 2019 American Transplant Congress

    Kidney Biopsies In Hiv-negative To Hiv-positive Kidney Transplants – An Institutional Experience

    V. Walavalkar1, A. Zarinsefat2, A. Urisman1, D. Dobi1, J. Vasquez3, P. Stock2, Z. Laszik1

    1Pathology, UCSF Medical Center, San Francisco, CA, 2Transplant Surgery, UCSF Medical Center, San Francisco, CA, 3Medicine, UCSF Medical Center, San Francisco, CA

    *Purpose: Increased life expectancy in HIV+ patients has resulted in an increase in CKD leading to ESRD; and therefore renal transplantation in these individuals is…
  • 2019 American Transplant Congress

    The Outcomes of Living Donor Kidney Transplantation in Donors or Recipients with Donors’ Renal Arteriosclerotic Lesions on Preoperative Computed Tomography

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

    Ehime University, Toon, Japan

    *Purpose: Living donor kidney transplantation is being increasingly performed with elderly donors. Such elderly donors often have arteriosclerotic lesions (AS) (Figure 1). Whether the outcomes…
  • 2019 American Transplant Congress

    Desensitization Protocols vs Kidney Paired Donation to Overcome AB0 Incompatibility and/or Donor Specific Antibodies in Living Donor Kidney Transplantation

    F. Vistoli, V. Perrone, L. Gozzini, E. Kauffmann, N. Napoli, S. Iacopi, C. Lombardo, G. Amorese, U. Boggi

    Pancreas and Kidney Transplantation Center, University of Pisa, Pisa, Italy

    *Purpose: International guidelines indicate Living Donor Kidney Transplantation (LDKT) as the best option for ESRD patients. Immunological barriers like AB0 incompatibility (AB0i) and donor specific…
  • « Previous Page
  • 1
  • …
  • 232
  • 233
  • 234
  • 235
  • 236
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences